Antifibrinolytic Agents: all 668 studies that test it

Page 7 of 7. Open to participants first (128), then studies with results posted, then the rest; newest registration first within each.

• Estradiol vs Lysteda in Treatment of Heavy Menstrual BleedingStatus unknownNCT01659008Not applicable
• Haemorrhage Alleviation With Tranexamic Acid- Intestinal SystemCompletedNCT01658124Phase 3
• Efficacy of Tranexamic Acid in Brain Tumor ResectionsStatus unknownNCT01655927Phase 3
• Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal SurgeryStatus unknownNCT01655641Phase 2/3
• Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver ResectionCompletedNCT01651182Phase 3
• Reduction Bleeding in Laminectomy With Double Doses of Tranexamic AcidCompletedNCT01643135Phase 4
• Reducing Post Operative Bleeding Following CabgCompletedNCT01600599Not applicable
• Can Tranexamic Acid Reduce Bleeding After Post Partum Hemorrhage in Cesarean Section DeliveryCompletedNCT01599468Phase 4
• Tranexamic Acid in On-pump CABG With Premature Clopidogrel CessationCompletedNCT01596738Not applicable
• Tranexamic Acid for Unilateral Total Knee ArthroplastyCompletedNCT01594671Phase 3
• Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?TerminatedNCT01535781Not applicable
• Vitamin K2 Intervention in Patients With Vitamin K AntagonistsCompletedNCT01533441Phase 2
• Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis PatientsCompletedNCT01528800Phase 2
• Epsilon Aminocaproic Acid Vs. Tranexamic Acid Vs. Placebo for Prevention of Blood Loss in Total Knee ArthroplastyStatus unknownNCT01527968Not applicable
• The Role of Inhalations of Tranexamic Acid in Patients With HemoptysisStatus unknownNCT01496196Phase 3
• Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin TherapyCompletedNCT01474460Not applicable
• Temporary Clamping of Drains Combined With Tranexamic Acid Reduce Blood Loss After TKA: A Prospective RCTCompletedNCT01449552Not applicable
• Clinical Randomisation of an Antifibrinolytic in Significant Head InjuryCompletedNCT01402882Phase 3
• Can we Use Intravenous Injection of Tranexamic Acid in Routine Practice With Active Management of the Third Stage of Labor?CompletedNCT01338454Phase 3
• Tranexamic Acid in Hip Fracture PatientsStatus unknownNCT01326403Not applicable
• Fibrin Glue or Tranexamic Acid for Total Knee ArthroplastyCompletedNCT01306370Phase 3
• Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)CompletedNCT01295294Phase 4
• Topical Application of Tranexamic Acid Reduces Postoperative Blood Loss in Total Hip ArthroplastyStatus unknownNCT01260818Not applicable
• Impact of Tranexamic Acid on Red Blood Cell Transfusion in Spinal SurgeryCompletedNCT01258010Not applicable
• The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease PatientsCompletedNCT01235325Phase 4
• Vitamin K as Additive Treatment in OsteoporosisStatus unknownNCT01232647Phase 2/3
• Tranexamic Acid and Pediatric AdenotonsillectomyCompletedNCT01228136Phase 4
• Tranexamic Acid in DacryocystorhinostomyStatus unknownNCT01221909Not applicable
• Comparison of Efficacy of Different Dosages Vitamin K2CompletedNCT01194778Not applicable
• Dose-ranging Study of Tranexamic Acid in Valve SurgeryCompletedNCT01191554Not applicable
• Evaluation of Factors II, VII, IX, X, and Proteins C and S, Following High-dose Vitamin K SupplementationCompletedNCT01143831Not applicable
• Tranexamic Acid (TXA) in Pediatric Cardiac SurgeryCompletedNCT01141127Phase 2
• Multicenter, Randomized Placebo-controlled Clinical Trial to Evaluate the Effect of Perioperative Use of Tranexamic Acid on Transfusion Requirements and Surgical Bleeding in Major Spine SurgeryCompletedNCT01136590Phase 4
• Intravenous Tranexamic Acid and Intraoperative Visualization During Functional Endoscopic Sinus SurgeryCompletedNCT01111669Not applicable
• Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic AcidSuspendedNCT01094977Phase 3
• Non-Idiopathic Scoliosis Treated With Tranexamic AcidTerminatedNCT01089140Phase 2
• The Effect of Tranexamic Acid on Postoperative Blood Loss and Coagulation in Patients With Preoperative Anemia Undergoing Off-Pump Coronary Artery Bypass Graft; Double Blind Randomized Control StudyCompletedNCT01067638Phase 4
• Hemostatic Effects of Ulinastatin and Tranexamic Acid in Cardiac SurgeryCompletedNCT01060189Not applicable
• Three Dose Regimen of Tranexamic Acid in Cardiac SurgeryStatus unknownNCT01060176Not applicable
• Tranexamic Acid in Clopidogrel Exposure to Decrease Hemorrhage and TransfusionCompletedNCT01060163Not applicable
• Effect of Tranexamic Acid in Upper Gastrointestinal BleedingWithdrawnNCT01005147Not applicable
• Tranexamic Acid in Pediatric Cardiac SurgeryCompletedNCT00994994Not applicable
• Topical Tranexamic Acid for Total Knee ArthroplastyCompletedNCT00985920Phase 4
• Amicar Pharmacokinetics of Children Having Craniofacial SurgeryCompletedNCT00912119Phase 1
• Comparing Different Routes and Doses of Phytonadione (Vitamin K) for Reversing Warfarin Treated Patients With Hip Fracture Before SurgeryWithdrawnNCT00905229Not applicable
• The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding DisordersCompletedNCT00904709Phase 4
• World Maternal Antifibrinolytic TrialCompletedNCT00872469Phase 3
• Nutritional Problems After Lung and Heart TransplantationStatus unknownNCT00826254Not applicable
• Dose-ranging Study of Two Doses of Tranexamic Acid During Cardiac SurgeryCompletedNCT00809393Phase 4
• Low Dose Supplementation to Improve Anticoagulation Control With Oral Vitamin K as an Adjuvant to Warfarin TherapyCompletedNCT00794755Phase 3
• The Use of Cyclokapron for Treatment and Management of Women With Bleeding DisordersCompletedNCT00697385Not applicable
• The Effect of Tranexamic Acid on Intraoperative and Post-Operative Bleeding in Functional Endoscopic Sinus SurgeryWithdrawnNCT00671281Not applicable
• Tranexamic Acid in Urologic SurgeryCompletedNCT00670345Phase 4
• A Preliminary Study of a New Tranexamic Acid Dosing Schedule for Cardiac SurgeryCompletedNCT00588133Phase 3
• Safety of Tranexamic Acid in Reducing Bleeding in Adults Undergoing Spinal SurgeryCompletedNCT00444470Phase 3
• Tranexamic Acid vs. Quixil - Reducing Blood Loss in Joint ReplacementCompletedNCT00378872Not applicable
• Tranexamic Acid, Hemorrhage and Transfusions After Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery.CompletedNCT00375466Not applicable
• Tranexamic Acid StudyWithdrawnNCT00375440Not applicable
• Clinical Randomisation of an Antifibrinolytic in Significant HaemorrhageCompletedNCT00375258Phase 3
• ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler SyndromeCompletedNCT00355108Phase 3
• Tranexamic Acid in HIp Fracture Surgery (THIF Study)CompletedNCT00327106Phase 3
• Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine SurgeryCompletedNCT00320619Not applicable
• Tranexamic Acid and Head and Neck Surgery PatientsStatus unknownNCT00308880Phase 3
• Daily Vitamin K in Patients on Warfarin With Unstable INRsCompletedNCT00287313Not applicable
• Clot Formation and Clot Stability in Patients With Severe Haemophilia ACompletedNCT00279578Not applicable
• Effect of Vitamin K on Age-Related Bone Loss and Vascular CalcificationCompletedNCT00183001Phase 3
• Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?CompletedNCT00147862Phase 3
• Oral Vitamin K for Warfarin Associated CoagulopathyCompletedNCT00143715Phase 3

← Antifibrinolytic Agents overview